- Home
- ONTO vs RVNC Comparison
ONTO vs RVNC Comparison
Compare ONTO & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTO
- RVNC
- Stock Information
- Founded
- ONTO 1940
- RVNC 1999
- Country
- ONTO United States
- RVNC United States
- Employees
- ONTO N/A
- RVNC N/A
- Industry
- ONTO Industrial Machinery/Components
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- ONTO Industrials
- RVNC Health Care
- Exchange
- ONTO Nasdaq
- RVNC Nasdaq
- Market Cap
- ONTO N/A
- RVNC 546.4M
- IPO Year
- ONTO N/A
- RVNC 2014
- Fundamental
- Price
- ONTO $217.89
- RVNC $5.28
- Analyst Decision
- ONTO Strong Buy
- RVNC Buy
- Analyst Count
- ONTO 8
- RVNC 10
- Target Price
- ONTO $261.67
- RVNC $10.86
- AVG Volume (30 Days)
- ONTO 662.1K
- RVNC 3.6M
- Earning Date
- ONTO 11-07-2024
- RVNC 11-06-2024
- Dividend Yield
- ONTO N/A
- RVNC N/A
- EPS Growth
- ONTO N/A
- RVNC N/A
- EPS
- ONTO 3.35
- RVNC N/A
- Revenue
- ONTO $897,213,000.00
- RVNC $251,178,000.00
- Revenue This Year
- ONTO $22.57
- RVNC $20.36
- Revenue Next Year
- ONTO $18.00
- RVNC $31.66
- P/E Ratio
- ONTO $65.00
- RVNC N/A
- Revenue Growth
- ONTO N/A
- RVNC 40.23
- 52 Week Low
- ONTO $108.98
- RVNC $2.30
- 52 Week High
- ONTO $238.93
- RVNC $9.90
- Technical
- Relative Strength Index (RSI)
- ONTO 59.07
- RVNC 39.70
- Support Level
- ONTO $204.76
- RVNC $5.13
- Resistance Level
- ONTO $211.71
- RVNC $5.41
- Average True Range (ATR)
- ONTO 8.13
- RVNC 0.20
- MACD
- ONTO 0.81
- RVNC -0.02
- Stochastic Oscillator
- ONTO 69.88
- RVNC 42.19
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.